Aemetis, Inc. (AMTX) - Q2 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2025. Aemetis, Inc. is a renewable natural gas and biofuels company operating three primary segments: California Ethanol (Keyes Plant), California Dairy Renewable Natural Gas (RNG), and India Biodiesel (Kakinada Plant). The company is also developing Sustainable Aviation Fuel (SAF) and Carbon Capture (CCUS) projects in California. As of July 31, 2025, there were 63,240,956 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | YTD 2025 (6 Months) |
|---|---|---|
| Revenue | $52.2 million | $95.1 million |
| Net Loss | $(23.4) million | $(47.9) million |
| Net Loss Per Share (Diluted) | $(0.41) | $(0.87) |
| Gross Loss | $(3.4) million | $(8.4) million |
| Operating Loss | $(10.7) million | $(26.2) million |
| Cash and Cash Equivalents | $1.6 million | $1.6 million (End of Period) |
| Total Debt | $344.2 million | $344.2 million |
| Current Ratio | 0.06 | 0.06 |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 21.5% year-over-year (Q2) and 31.7% year-over-year (YTD). The India Biodiesel segment saw a significant 52.1% drop in Q2 revenue due to delays in government tender contracts and a shift to fixed pricing. California Ethanol revenue declined 7.1% due to a strategic 15% reduction in throughput to optimize yields.
- Profitability: The company reported a net loss of $23.4 million for Q2 2025, an improvement from the $29.2 million loss in Q2 2024. However, the gross loss widened to $(3.4) million in Q2 2025 compared to $(1.8) million in Q2 2024, driven by higher feedstock costs in India and increased depreciation in the RNG segment.
- Debt Structure: Total debt increased slightly to $344.2 million. A significant portion ($270.6 million) is classified as current debt, maturing within the next 12 months. The company refinanced the Aemetis Biogas Series A Preferred Units, requiring redemption by August 31, 2025, or conversion to a new credit agreement.
- Cash Flow: Net cash used in operating activities improved to $(5.6) million for the six months ended June 30, 2025, compared to $(15.4) million in the prior year period, aided by a $12.3 million receipt from tax credit sales.
Guidance, Outlook, and Risks
- Liquidity and Going Concern: Management has concluded there is substantial doubt about the company's ability to continue as a going concern for the next twelve months due to high debt levels, reliance on senior lender extensions, and negative operating cash flows.
- Strategic Initiatives:
- California Ethanol: Implementing Mechanical Vapor Recompression (MVR) to reduce natural gas use by 80% and lower carbon intensity, expected operational in H1 2026. Monetizing new Section 45Z tax credits effective Jan 1, 2025.
- RNG: Operating 11 digesters with plans to expand. Recent CARB approvals for provisional pathways are expected to double LCFS credit revenue from specific dairies starting Q3 2025.
- India: Planning a potential IPO for the India subsidiary and hiring a new executive team to drive growth.
- Financing: The company is raising cash through at-the-market equity sales (raised $18.0 million YTD) and seeking to refinance debt maturing in 2026. Future liquidity depends on the cooperation of senior lender Third Eye Capital.
- Risks: Key risks include the inability to refinance debt, volatility in feedstock and product prices, delays in government tenders (India), and regulatory changes affecting tax credits and LCFS pathways.
Investor Verification Checklist
- Debt Maturity Wall: Verify the status of refinancing for the $270.6 million in debt due within 12 months and the specific terms of the Aemetis Biogas Series A Preferred Unit redemption/conversion due August 31, 2025.
- India Tender Status: Confirm the timeline for the resumption of government tender contracts in India, which caused a 74.6% revenue drop YTD.
- Tax Credit Monetization: Assess the actual cash proceeds received from Section 45Z and LCFS credits versus the projected revenue improvements cited in management commentary.
- Equity Dilution: Monitor the rate of at-the-market stock sales required to fund operations, noting the issuance of 10 million shares YTD.
- Internal Controls: Review the status of remediation plans for material weaknesses in IT general controls and financial reporting identified in the previous 10-K.